Tetrahedron Letters
3
Ed., 2012, 51, 1; e) Rueping, M.; Tolstoluzhsky, N. Org.
Lett. 2011, 13, 1095; f) Komai, H.; Yoshino, T.;
Matsuguna, S.; Kanai, M. Org. Lett. 2011, 13, 1706; g)
Qian, B.; Xie, Y.; Huang, H. Org. Lett. 2011, 13, 2580; h)
Burton, M. P.; Morris, A. J. Org. Lett. 2010, 12, 5359; i)
Qian, B.; Guo, S.; Shao, J.; Zhu, Q.; Yang, L.; Xia, C.;
Huang, H. J. Am. Chem. Soc. 2010, 132, 3650; j) Tobisu,
M.; Chatani, N. Angew. Chem. Int. Ed. 2006, 45, 1683; k)
Kakiuchi, F.; Chatani, N. Adv. Synth. Catal. 2003, 345,
1077.
128.5, 127.4, 126.6, 126.2, 121.6, 119.2, 111.1, 110.7,
79.7, 55.6, 43.4, 42.2, 29.5; m/z (ESI); 353 [M+H]+.
2-(2-(benzo[d][1,3]dioxol-5-yl)-3-nitropropyl)quinoline
(3b) IR: νmax 2956, 2924, 2855, 1600, 1551, 1503, 1487,
1
1444, 1377, 1247, 1039, 934, 819, 751 cm-1; H NMR
(300 MHz, CDCl3): δ 8.01-8.11 (m, 2H), 7.65-7.81 (m,
2H), 7.45-7.55 (m, 1H), 7.28 (d, J = 3.02 Hz, 1H), 7.15 (d,
J = 8.3 Hz, 1H), 6.75 (s, 1H), 6.69 (s, 1H), 5.90 (s, 2H),
4.62-4.83 (m, 2H), 4.06-4.23 (m 1H), 3.31 (d, J = 7.5 Hz,
2H); 13C NMR (75 MHz, CDCl3): δ 158.3, 147.9, 147.7,
147.5, 136.6, 129.6, 129.4, 128.8, 127.5, 126.2, 125.6,
121.6, 120.8, 108.4, 107.6, 101.0, 79.8, 43.6, 42.3; m/z
(ESI); 307 [M+H]+.
3. Meshram, H. M.; Nageswara Rao, N.; Chandrasekhara
Rao, L.; Satish Kumar, N. Tetrahedron Lett. 2012, 53,
3963.
4. a) Iaroshenko, V. O.; Knepper, I.; Zahid, M.; Kuzora, R.;
Dudkin, S.; Villinger, A.; Langer, P. Org. Biomol.Chem.
2012, 10, 2955; b) Henry, D. Tetrahedron, 2004, 60,
6043; c) Lehn, J.-M. Science 2002, 295, 2400; d) Baxter,
P. N. W.; Lehn, J. M.; Fischer, J.; Youinou, M. T. Angew.
Chm. Int. Ed. 1994, 33, 2284.
5. a) De Rosa, M.; Soriente, A. Tetrahedron 2010, 66, 2981;
b) Vivek, P.; Varma, R. S. Tetrahedron Lett. 2007, 48,
8735; c) Sarah, M.; Alexandre, A. Org. Lett. 2006, 8,
3577; d) Kappe, C. O. Angew. Chm. Int. Ed. 2004, 43,
6250; e) Mats, L.; Christan, M.; Anders, H. Acc.Chem.
Res. 2002, 35, 717; f) Varma, R. S. Green. Chem. 1999, 1,
43.
6. a) Pateliya, M. H.; Veerababurao, K.; Chun-wei, K.;
Ching-Fa, Y. Tetrahedron Lett. 2008, 49, 7005; b) Khatik,
G. L.; Kumar, R.; Chakraborti, A. K. Org. Lett. 2006, 8,
2433; c) Kavala, V.; Samal, A. K.; Patel, B. K. ARKIVOC
2005, i, 20; d) Azizi, N.; Saidi, M. R. Org. Lett. 2005, 7,
3649; e) Maggi, R.; Bigi, F.; Carloni, S.; Mazzacani, A.;
Sartori, G. Green Chem. 2001, 3, 173; f) Li, C. J. Chem.
Rev. 1993, 93, 2023.
7. General procedure: A sealed 10 mL glass tube containing
nitrostyrene (1 equiv.), methyl quinoline (1.5 equiv.) and
water (3 mL) was placed in the cavity of a microwave
reactor and irradiated for appropriate time, at 1020C
(temperature monitored by built in infrared sensor), and
power 150 W. After cooling to room temperature by an
air-flow, the tube was removed from the rotor. The
reaction mixture was diluted with water and extracted with
ethyl acetate. The combined ethyl acetate extracts were
then dried over Na2SO4 and after removal of the solvent
the mixture was purified by (silica gel) column
chromatography (hexane/AcOEt, 80:20 as eluent) to give
pure products.
2-(2-(4-methoxyphenyl)-3-nitropropyl)quinoline (3c) IR:
νmax 2926, 2841, 1606, 1550, 1510, 1377, 1250, 1179,
1
1032, 830, 769 cm-1; H NMR (300 MHz, CDCl3): δ 8.04
(d, J = 8.4 Hz, 1H), 7.86-7.95 (m, 1H), 7.58-7.71 (m, 2H),
7.37-7.46 (m, 1H), 7.12 (d, J = 6.9 Hz, 2H), 6.99-7.07 (m,
1H), 6.70-6.79 (m, 2H), 4.60-4.81 (m, 2H), 4.09-4.21 (m,
1H), 3.63 (s, 3H), 3.27 (d, J = 6.6 Hz, 2H); 13C NMR (75
MHz, CDCl3): δ 158.5, 158.2, 147.3, 136.1, 130.8, 129.2,
128.4, 128.2, 127.2, 126.4, 125.8, 121.4, 113.8, 79.5, 54.6,
42.8, 41.9; m/z (ESI); 323 [M+H]+.
2-(3-nitro-2-p-tolylpropyl)quinoline (3d) IR: νmax 2924,
1
2854, 1599, 1551, 1507, 1428, 1377, 819, 749 cm-1; H
NMR (300 MHz, CDCl3): δ 8.03 (dd, J = 8.8 Hz, J = 1.7
Hz, 2H), 7.65-7.79 (m, 2H), 7.45-7.53 (m, 1H), 7.24-7.34
(m, 1H), 7.05-7.17 (m, 4H), 4.66-4.85 (m, 2H), 4.11-4.23
(m, 1H), 3.34 (d, J = 7.7 Hz,.2H), 2.28 (s, 3H); 13C NMR
(75 MHz, CDCl3): δ 158.5, 147.7, 137.2, 136.5, 136.2,
129.6, 129.5, 128.9, 127.4, 127.2, 126.8, 126.1, 125.7,
121.9, 121.6, 79.7, 43.4, 42.4, 29.6; m/z (ESI); 307
[M+H]+.
2-(3-nitro-2-phenylpropyl)quinoline (3e) IR: νmax 2956,
2924, 2854, 1599, 1551, 1501, 1457, 1376, 1261, 822, 752
1
cm-1; H NMR (300 MHz, CDCl3): δ 8.03 (dd, J = 14.3
Hz, J = 8.1 Hz, 2H), 7.64-7.79 (m, 2H), 7.50 (t, J = 6.9
Hz, 1H), 7.20-7.32 (m, 5H), 7.11 (d, J = 8.3 Hz, 1H),
4.68-4.89 (m, 2H), 4.14-4.27 (m, 1H), 3.35 (d, J = 7.3 Hz,
2H); 13C NMR (75 MHz, CDCl3): δ 158.3, 147.6, 139.2,
136.5, 129.6, 128.7, 127.5, 127.4, 127.3, 126.7, 126.7,
126.1, 125.7, 121.9, 121.5, 79.5, 43.7, 42.2; m/z (ESI);
293 [M+H]+.
2-(2-(4-chlorophenyl)-3-nitropropyl)quinoline (3f) IR:
νmax 2924, 2855, 1598, 1552, 1497, 1376, 1093, 826, 752
1
cm-1; H NMR (300 MHz, CDCl3): δ 7.99-8.10 (m, 2H),
7.65-7.81 (m, 2H), 7.50 (t, J = 7.5 Hz, 1H), 7.08-7.35 (m,
5H), 4.66-4.88 (m, 2H), 4.16-4.28 (m, 1H), 3.24-3.38 (m,
2H); 13C NMR (75 MHz, CDCl3): δ 157.8, 147.7, 137.7,
136.6, 136.4, 129.7, 128.9, 128.8, 127.5, 127.4, 126.3,
121.9, 121.5, 79.3, 42.0, 43.0; m/z (ESI); 327 [M+H]+.
2-(2-(4-bromophenyl)-3-nitropropyl)quinoline (3g) IR:
νmax 2924, 2853, 1598, 1551, 1488, 1428, 1377, 1073,
8. Spectral data of representative compounds:
12-(2-(3, 4-dimethoxyphenyl)-3-nitropropyl)quinoline (3a)
IR: νmax 3006, 2927, 1597, 1550, 1514, 1461, 1427, 1378,
1262, 1144, 1026, 823 cm-1; 1H NMR (300 MHz, CDCl3):
δ 8.04 (dd, J = 8.1 Hz, J = 2.8 Hz, 2H), 7.76 (d, J = 8.1
Hz, 1H), 7.67-7.74 (m, 1H), 7.51 (t, J = 7.9 Hz, 1H), 7.14
(d, J = 8.4 Hz, 1H), 6.77-6.81 (m, 2H), 6.72 (d, J = 1.5 Hz,
1H), 4.69-4.85 (m, 2H), 4.10-4.22 (m, 1H), 3.81 (s, 3H),
3.77 (s, 3H), 3.36 (d, J = 7.7 Hz, 2H); 13C NMR (75 MHz,
CDCl3): δ 158.3, 148.8, 148.2, 147.4, 136.6, 131.4, 129.6,
1
1010, 826, 756 cm-1; H NMR (300 MHz, CDCl3): δ 8.02
(t, J = 8.4 Hz, 2H), 7.66-7.77 (m, 2H), 7.45-7.53 (m, 1H),
7.38 (d, J = 8.3 Hz, 2H), 7.11 (dd, J = 8.3 Hz, J = 3.3 Hz,
3H), 4.66-4.87 (m, 2H), 4.16-4.27 (m, 1H), 3.23-3.38 (m,
2H); 13C NMR (75 MHz, CDCl3): δ 157.8, 147.6, 138.2,